13 recent lawsuits involving pharma companies, PBMs, distributors

Below are 13 legal actions involving the drug supply chain, including pharmaceutical companies, PBMs and distributors, reported by Becker's Hospital Review in the last month.

1. Biotech accuses Dr. Soon-Shiong of orchestrating a 'catch and kill' scheme to protect cancer drug
A California biotech claims that controversial billionaire biotech entrepreneur Patrick Soon-Shiong, MD, orchestrated a "catch and kill" scheme to stop development of an experimental cancer drug that may have saved the U.S. healthcare system more than $1 billion.

2. Novartis must face trial over alleged physician kickbacks, judge rules
A federal  judge in New York has ruled that Novartis must face trial in a case accusing the drugmaker of paying millions of dollars in kickbacks to physicians to boost prescription rates.

3. Class-action suit against Mylan over EpiPen will go forward, judge rules
Mylan must face a class-action lawsuit over its lifesaving allergy treatment EpiPen, a judge ruled March 29.

4. New York sues 6 opioid manufacturers, 4 distributors, the Sacklers
The New York attorney general is suing six opioid manufacturers, the Sackler family and four prescription drug distributors in a massive legal fight against the pharma industry accused of fueling the opioid crisis.

5. J&J cleared of liability in New Jersey talc case
In the latest talc trial, a New Jersey jury decided Johnson & Johnson was not liable for causing a man's mesothelioma.

6. 3 drugmakers settle lawsuit claiming they stifled generic competition
Three generic drugmakers — Teva Pharmaceuticals, Mylan and Ranbaxy —  will pay $65.9 million to settle claims that they engaged in a scheme promoting anticompetitive behavior.

7. Purdue Pharma to pay $270M to settle Oklahoma opioid lawsuit
OxyContin maker Purdue Pharma and the billionaire Sackler family will pay $270 million to resolve Oklahoma's claims that the company helped fuel the opioid epidemic.

8. Dr. Reddy's legal win expected to lower cost of opioid addiction treatment
After a two-year legal battle, Dr. Reddy's Laboratories has won the right to sell a cheaper version of a best-selling opioid addiction treatment in the U.S.

9. Roche sues US execs, says diabetes test strips fraudulently resold
Roche has sued more than a dozen former executives at Alliance Medical Holdings over what the drugmaker calls fraudulent schemes involving its diabetes test strips.

10. Ohio sues OptumRx to recover $16M in alleged overcharges
Ohio Attorney General Dave Yost is suing pharmacy benefit manager OptumRx to recoup $16 million in alleged overcharges.

11. Judge tosses suit alleging Express Scripts 'stole' patients
A federal judge dismissed a lawsuit filed by six pharmacies that claimed Express Scripts violated health privacy laws and poached customers.

12. J&J hit with $29M verdict in California talc case
A California jury ordered Johnson & Johnson to pay $29 million to a woman who alleged that asbestos in the company's talc-based baby powder caused her fatal cancer.

13. Novartis to pay $23M to settle claims it used charity payments as kickbacks
Pharma giant Novartis agreed to pay $23 million to settle allegations that it used charities to pay kickbacks to Medicare patients to cover their out-of-pocket costs.

More articles on pharmacy:
7 drugs projected to become blockbusters by 2023
3 insulin manufacturers to testify at House panel April 10
Cigna-Express Scripts cap out-of-pocket 30-day insulin costs at $25

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months